Changes in Missouri Law Linked to Increased Breast Cancer Screening Rates

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

THURSDAY, July 31, 2025 -- Changes in Missouri law expanding breast cancer screening coverage have led to increased screening rates among Medicaid patients and an increased likelihood of digital breast tomosynthesis (DBT) among those undergoing screening, according to a study published online July 22 in the Journal of the American College of Radiology.

Amy K. Patel, M.D., from The Breast Care Center at Liberty Hospital in Missouri, and colleagues examined the effect of Missouri law changes (i.e., expanding mammography coverage to include annual screening from age 40) on overall screening rates and use of DBT in a retrospective study using a national claims database for 2015 to 2022.

Data were included for 1,008,881 unique women (41.4 percent in Missouri). The researchers found that women with Medicaid and commercial insurance had a greater increase in the likelihood of screening mammography after the Missouri law change compared to women with Medicare Advantage whose coverage is based on federal law (odds ratios, 1.45 and 1.05, respectively). The likelihood of DBT was higher for women with Medicaid for both within-Missouri and border-state comparisons (odds ratios, 2.31 and 1.24, respectively). Likewise, a relative increase in likelihood of receiving DBT was seen for commercially insured women.

"This study shows that policy change matters -- and can improve access to lifesaving screening," Patel said in a statement. "In Missouri, where we face some of the nation's worst disparities in breast cancer outcomes, this legislation is moving the needle in the right direction."

One author disclosed ties to Hologic, Beekley Medical, Bayer, and SuperSonic Imagine.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-01 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords